Study: Enzyme could be potential drug target for rare leukemia

09/17/2008 | Reuters

U.S. scientists found that blocking the enzyme glycogen synthase kinase, which can combat certain cancers, by using a drug for bipolar disorder helped prolong the life of mice with mixed-lineage leukemia, a rare form of disease that affects infants. The finding may prove useful in developing "better inhibitors that can be administered long term," one of the researchers said.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Fort Worth, TX
Director, Senior Legal Counsel
Fort Worth, TX
Corporate Counsel - Healthcare Law Group
South San Francisco, CA
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC